Call MEDISCA now at 1-800-932-10391300 786 392


#HERETOHELP: A COVID-19 RESPONSE

MEDISCA, MEDISCA Network, and LP3 Network are dedicated to collectively utilizing resources to provide compounding pharmacists on the frontlines with the practical support they require to navigate through these challenging times. From potential drug shortage formulation support from MEDISCA Network, to COVID-19 education program and online education solutions from LP3 Network, to chemical and product supplies from MEDISCA, together, we are #HERETOHELP.




Filter by:



5/15/2020

COVID-19 Comprehensive Global Pharmacist Support Document

Pharmacist Support Document-Available For Free

From the first news of a novel coronavirus being discovered, to the official classification of a global pandemic due to COVID-19, information regarding temporary and emergency protocols, proposed guidelines as well as public safety recommendations, to name a few, have continually been updated and revised as more information regarding the virus is discovered. Heath care providers, such as pharmacists, search for credible sources of information to not only educate themselves on this pandemic but on how to advise and care for their patients as well. In an effort to help consolidate the most up-to-date regulatory and professional organizational guidelines and policies, MEDISCA Network has created a document to serve the healthcare community as a resource for providing such information. Some of the major topics of concern have been included and are subcategorized by the countries of Australia, Canada and the United States as well as other potentially relevant international documents. We are #heretohelp the global compounding industry!

Click Here to View the Pharmacist Support Document.

 

 

 


4/22/2020

Over 100 Potential Shortage Support Formulas – Available For Free!

MEDISCA Network makes keeping up with FDA, ASHP, Health Canada, and TGA shortage lists appear easy with the number of formulas they keep rolling out!

Over the last month, MEDISCA Network’s formulation department has worked around the clock developing formulas to support compounding pharmacists address drug shortages accumulating across the globe in consequence of COVID-19 manufacturing disruptions.

From antiseptic solutions, to critical care medications, to antipyretics, analgesics, sedatives, disease-modifying anti-rheumatic drugs, antimicrobials, and much more, MEDISCA Network has published over 100 formulas, to date (and growing), in support of potential shortages. Further to this, all of the shortage support formulas are FREELY accessible on MEDISCA Network’s Potential Shortage Support webpage…!

“Our primary objective right now is to provide the resources and expertise support that our compounding pharmacists on the frontlines need during this critical time” said Marlene Abouassaly, Technical Support Service Manager at MEDISCA Network, “and formulas are such an essential part of the compounding process”. All of MEDISCA Network’s formulas are  fully referenced with details on ingredient quantities, special ingredient considerations, calculation templates, preparatory instructions, estimated BUDs, package requirements, auxiliary labels, and more. Certain formulas, such as Hydroxychloroquine Sulfate 25 mg/mL oral liquid, also have references for extended beyond-use dates (BUD); in this particular case, a BUD of 90 days when compounded in MEDISCA’s Oral Mix and packaged in PrecesieDose™ Syringes. In determining shortage support needs, MEDISCA Network’s team is staying ahead of the curve by closely monitoring shortage list updates published by the FDA, ASHP, Health Canada, and the TGA.

To further support pharmacists during these times, for the remainder of the month, MEDISCA Network will be offering 10% discounts on all their Technical Support Service bundle packages for new subscribers. Package options include access to a databank of 8,000+ formulas, customized formulation design, consultation services, and a dedicated customer support help line. From formulation chemists, to compounding pharmacists, and lab technicians MEDISCA Network’s team has made it clear they are #HERETOHELP. For more details visit here and/or contact MEDISCA Network at information@medisca.net.


4/16/2020

Can a government stimulus package benefit your pharmacy?

We have researched how government stimulus packages could benefit compounding pharmacies around the world. Read through the following information to see how your business might be effected. We are #Heretohelp.

United States

  • US lawmakers have passed $2 trillion stimulus package. The legislation includes direct payments to individuals, a boost to unemployment benefits and a $500 billion lending program.
  • Congress has already approved more than $112 billion to ramp up vaccine research and provide two weeks of paid sick leave for those who are being tested or treated for COVID-19.
  • The Federal Reserve has let loose a tsunami of stimulus measures in recent days. That includes an initial pledge to purchase $700 billion in US Treasuries and mortgage-backed securities, which now has no cap and can include corporate bonds and bond exchange-traded funds. The Fed also announced $300 billion in new financing to keep credit flowing to businesses and consumers.

Canada

  • In a rare session, Canadian lawmakers passed legislation that will subsidize up to 75% of workers’ salaries to avoid even more mass layoffs during the COVID-19 pandemic.
  • Canadian Prime Minister Justin Trudeau, now out of quarantine after his wife tested positive for the virus in March, attended the scaled-down session with a "quorum" of about 20 lawmakers.
  • Opposition parties joined Trudeau’s governing party to unanimously approve the wage-subsidy scheme, which will cost more than $50 billion (in US currency) and will be applied retroactively to days worked since March 15.
  • A majority of Canadian companies are likely to qualify for the subsidy.

Australia

  • Other stimulus measures include inexpensive bank financing which is aimed to stimulate borrowing, part of this was announced by the Reserve Bank of Australia.
  • The government also announced a $20 billion loan guarantee to help impacted small/medium-sized businesses meet cash flow requirements. If you include these total loan guarantees with the direct fiscal stimulus, then the total stimulus in the economy is worth around 10% of GDP.
  • There are also RBA interest rate cuts and three-year government bond purchases to meet the 0.25% yield target. 
  • Details of the package announced to include: increase the payment of the Newstart allowance (an additional $550/fortnight) and expanded eligibility for income support (the Newstart allowance). It also includes:
    • Further $750 payment (on top of the $750 already announced) for those on welfare support (5.2 million Australians), and Job Keeper Payments
    • Early access to superannuation for those whose wages have been directly affected by the virus (draw up to $10K from superannuation this and next financial year) tax-free, 
    • More flexibility around retirees on drawing down on their superannuation and increasing cash payments to SMEs ($20K payment up to $100K).
  • The Prime Minister said that more stimulus initiatives are likely, and citizens should expect more direct cash handouts to Australian households to be announced over the next few weeks. 

United Kingdom

  • The UK government has unveiled £330 billion ($397 billion) in loan guarantees and suspended local business taxes for the retail, hospitality and leisure sectors for 12 months. It will also cover 80% of workers' salaries for at least the next three months, up to a maximum of £2,500 ($2,900) a month. It's unclear how much that initiative will cost.
  • In addition, the UK government promised to provide the self-employed with a cash grant of 80% of their average monthly profit, up to £2,500 ($3,000) a month, over the next quarter.
  • The Bank of England has said it will increase its holdings of UK government and corporate bonds by £200 billion ($242 billion).

European Union

  • Germany has unveiled a rescue package worth up to €750 billion ($825 billion) that includes measures to spur lending to businesses and take direct stakes in companies.
  • France has approved €45 billion ($50 billion) in relief for small businesses and unemployed workers. It is also guaranteeing €300 billion ($330 billion) in corporate borrowing.
  • Italy has greenlit €25 billion ($27.5 billion) to help workers and support the country's health system, while Spain has put up €200 billion ($220 billion).
  • The European Central Bank has said it will spend €750 billion ($824 billion) buying government debt and private securities before the end of 2020, and stands ready to do more if necessary. That's on top of €120 billion ($133 billion) in extra purchases it announced previously.

China

  • So far, China has announced at least 116.9 billion yuan ($16.4 billion) in financial relief and stimulus, plus 800 billion yuan ($112.5 billion) in tax and fee reductions. .
  • The People's Bank of China has adopted various credit easing measures, allocating at least 1.15 trillion yuan ($162 billion) to help businesses hit by the virus.

4/1/2020

MEDISCA Announces NEW Live Stream Education – Attend Seminar and Receive CPE Credits from Home

MEDISCA Announces NEW Live Stream Education – Attend Seminar and Receive CPE Credits from Home

To support the COVID-19 isolation measures and MEDISCA's commitment to providing industry-leading continuing healthcare education, MEDISCA is happy to announce that they will be bringing their North American live seminars to your home through live streaming solutions. This innovative learning experience allows you to attend seminars and receive Continuing Pharmacy Education (CPE) credits (as you would if you were in person) from the comfort and safety of your home. “In real time, you will connect with fellow peers and facilitator(s), virtually through our online learning platform” said MEDISCA  General Manger, Maurizio De Stefano. “This platform will allow you to see and interact with subject-matter experts as they light up the stage from their living room to yours!”

A list of upcoming MEDISCA  Live Stream Seminars and links to their corresponding course pages can be found below:

Contact Information: sales_au@medisca.com | www.medisca.com.au | 1300 786 392


3/27/2020

World Congress of Compounding 2020 – Cancelled

World Congress of Compounding 2020 – Cancelled

As a result of the COVID-19 pandemic, MEDISCA, MEDISCA Network, and LP3 Network have decided to cancel the World Congress of Compounding Event scheduled to be held at ARIA, Las Vegas on October 2-3, 2020. Given the uncertainty we are currently facing, we have decided to be proactive as there is no higher priority for us than the health, safety, and physical well-being of each of you, together with everyone else involved in the event.

Contact Information: info@compoundingcongress.com | www.compoundingcongress.com | 1-866-833-5318


3/23/2020

MEDISCA Network Adds Formulations to their Potential Shortage Support Page

MEDISCA Network Adds Formulations to their Potential Shortage Support Page

MEDISCA Network is closely monitoring potential shortages occurring across North America and Australia on a daily basis. In the last week, MEDISCA Network has added acetaminophen, epinephrine, diltiazem, bumetanide, hydroxychloroquine, chloroquine, lopinavir-ritonavir, and vitamin D3 formulations among more. All potential shortage formulations are freely accessible to all. For a full list and access to formulations that may address potential shortages, please visit the following address:

 

Contact Information: information@medisca.net | www.medisca.net | 1-866-333-7811


3/20/2020

MEDISCA Announces COVID-19 Webinar – Mitigating Risk, Addressing Shortages, Achieving Therapeutic Needs

MEDISCA Announces COVID-19 Webinar – Mitigating Risk, Addressing Shortages, Achieving Therapeutic Needs

As the impact of COVID-19 on pharmacies becomes more apparent, MEDISCA is ramping up efforts to develop a webinar addressing the latest empirical evidence on COVID-19 transmission and management. The webinar will place special attention to the compounding pharmacist’s role in mitigating risk, addressing shortages, and achieving therapeutic needs. The webinar will be airing live across the globe next Thursday, March 26, 2020 at 5:00 pm EDT (2:00 pm PDT or 9:00 pm GMT or Friday, March 27, 2020 at 8:00 am AEDT). This webinar is open to all and is freely accessible at the following link. The webinar will be recorded and made available on-demand after the live webinar.

 

Contact Information: sales_au@medisca.com | www.medisca.com.au | 1300 786 392


3/13/2020

MEDISCA Announces COVID-19 Prevention Procedures & Product Update

MEDISCA Announces COVID-19 Prevention Procedures & Product Update

Prevention Procedures

As a company spanning over 50 countries around the world, we are witnessing the widespread effect of the Coronavirus (COVID-19) and are dedicated to minimizing the spread of this global pandemic. As such, the following procedures have been put in place and are effective immediately:

  • All business travel has been suspended including meetings, conferences, tradeshows, events, etc. for the immediate future.
  • Cancellation/postponement of the following MEDISCA  Australia Training Activities:
    • Nutraceutical Therapy- An Integrative and Function Approach, scheduled 17-18 April, 2020, in Melbourne: Cancelled until further notice
    • Achieving Best Practices - Sterile Compounding, scheduled 24-26 May, 2020, in Sydney: Cancelled until further notice
    • The Science of Pharmaceutical Compounding - Non-Sterile Training, scheduled 29-31 May, 2020, in Sydney: Cancelled until further notice
    • Nutraceutical Compounding Laboratory Training, scheduled 1 June, 2020, in Sydney: Cancelled until further notice
    • Dermatology Compounding Laboratory Training, scheduled 1 June, 2020, in Sydney: Cancelled until further notice

    Medisca Australia currently remains available as posted on their site (https://www.medisca.com.au/healthcare-courses).  The upcoming Nutraceutical course in April is currently under evaluation and registrants will be notified of any changes.

    MEDISCA has swiftly taken action and contacted all participants registered to the cancelled training programs in March and April ensuring a solution has been provided for future enrollments and credits on file extended until December 2020.  For any additional information, certainly contact  sales_au@medisca.com or 1300 786 392.

  • Outside sales representatives will conduct business from home to provide support for their customers and avoid visiting pharmacies in person.
  • Heightened restrictions for visitors to our locations worldwide, relying heavily on teleconferencing to conduct business.
  • Enhanced daily professional cleaning of all common areas in MEDISCA facilities
  • Providing necessary resources to our team to encourage continuity of work in case of voluntary quarantine.

We recognize that these cancellations and changes will inconvenience many of our customers and we sincerely apologize for the disruption. As we continue to put the health and safety of our team, customers, and pharmacies as our first priority, we ask for your patience and cooperation in working to end this pandemic.

 

Product Availability

We appreciate you choosing MEDISCA as your compounding partner and would like to honor that relationship by continuing to supply you with high-quality products throughout this crisis. Although some products are in shortage industry-wide, we are working to minimize supply chain issues and would ask that you place orders based on your current needs and typical inventory flow.  Please note that some items (like facemasks, 70% IPA) are out of stock or in short supply but inventory is being replenished.  We will continue to closely monitor the shortages and keep you informed of any updates. 

We would also like to provide your pharmacies with resources and services that may enhance your ability to serve in this time of need. Compounding can offer relief and stability during traditional drug shortages and MEDISCA can help formulate alternative options for all wellness needs, including sanitizing, nutraceutical and medication needs. Please contact MEDISCA Network for ideas as your resource to formulas that could benefit your community and improve the overall health of your patients. Visit our page for available sample formulas to assist you in this time of need https://www.medisca.net/technical-services/tss/shortage-support or call us at 1-866-333-7811 for any additional support.

 

Product and Packaging Safety

We have received several questions regarding the possibility of the virus spreading via product surfaces or packaging, and would refer you to statements made by the Center for Disease Control (CDC) and the World Health Organization (WHO):

“In general, because of poor survivability of these coronaviruses on surfaces, there is likely very, very low risk of spread from products or packaging that are shipped over a period of days or weeks at ambient temperatures.”

       - Dr. Nancy Messonnier, CDC Director for Immunization and Respiratory Diseases, 26 February 2020

“The likelihood of an infected person contaminating commercial goods is low and the risk of catching the virus that causes COVID-19 from a package that has been moved, travelled, and exposed to different conditions and temperature is also low.”

       - WHO Website “Q&A on Coronavirus (COVID-19)”, 9 March 2020




PRODUCT SUPPORT

Are you short staffed? Let automation do the work for you!

See how MEDISCA's exclusive technologies can help ease your workload and stress without ever compromising quality.

Animated Banner Animated Banner


MAZ Mixer

Consumable Cost Savings


Unparalleled Efficiency


Consistent High Quality

MAZ Mixer

Workhorse Quality


Supplier Reliability


Leak-Resistant Jars


The SAMIX® Jars,

Versatile and can be used perfectly for mixing and dispensing

Jar



DON'T TAKE OUR WORD FOR IT, PHARMACISTS' REVIEWS

Star Star Star Star Star

Rob, IHC Pharmacy, Dayton, Ohio

RECOMMENDS THE MAZ

We've had the MAZ for years and we LOVE it! I've been compounding for about 18 years and this is a game changer! The time we saved using the MAZ is unmeasurable. With half staff and patients panicking to get their meds, I've been able to keep up... thanks to the MAZ!

Star Star Star Star Star

AJ Asgari, Meds and Moore Pharmacy

RECOMMENDS SAMIX MIXERS

During this very busy time, and due to the overwhelming needs of my patients, I recently invested in a second SAMIX mixer for my pharmacy. The efficiency of the machine has allowed us to keep the workflow steady and prescription deliveries on time!

Star Star Star Star Star

Justin Clark, Civic Center Pharmacy

RECOMMENDS THE MAZ

The MAZ has been an extremely valuable asset to our Pharmacy during this pandemic, allowing us to complete the large influx of compounded prescriptions refills rapidly, while still giving us the time to create bulk hand sanitizer for patients coming to the pharmacy. Which has brought in a new revenue stream for us.



FIND OUT HOW MEDISCA IS #HERETOHELP


SHOP NOW



Live Virtual Seminars

To support the COVID-19 isolation measures, LP3 Network will be bringing their North American live seminars to your home through live streaming solutions. This innovative learning experience allows you to attend seminars and receive Continuing Pharmacy Education (CPE) credits (as you would if you were in person) from the comfort and safety of your home. In real time, you will connect with fellow peers and facilitator(s), virtually through LP3 Network’s online learning platform. This platform will allow you to see and interact with subject-matter experts as they light up the stage from their living room to yours!





A list of upcoming LP3 Network Live Virtual Seminars and links to their corresponding course pages can be found below:


View upcoming Live Virtual Seminars
Laptop




COVID-19 WEBINAR

As the impact of COVID-19 on pharmacies became significant, LP3 Network’s team quickly ramped up efforts to develop a webinar addressing the latest empirical evidence on COVID-19 transmission and management, with special focus on the compounding pharmacist’s role in mitigating risk, addressing shortages, and achieving therapeutic needs. The webinar aired live on March 26, 2020 and the recording can be found online and is freely accessible to all:

COVID-19: The Pharmacist’s Role in Mitigating Risk, Addressing Shortages, and Attending to Therapeutic Needs

ONLINE EDUCATION SUBSCRIPTION PLAN

While isolation measures continue, you can also take advantage of LP3 Network’s online subscription plan featuring over 35 webinars and eLearning programs covering the latest hot topics (cannabis-based therapy, opioid use), niche markets (hormones, dermatology, vet, pediatrics, nutraceuticals), regulatory updates, pharmaceutical calculations and procedures, among more. Benefit from education that you can take from the comfort and safety of you home.

LP3 Network’s Online Education Subscription Plan





LP3 Network Contact Information: info@lp3network.com | www.lp3network.com | 1-844-408-9453

MEDISCA Australia Contact Information: sales_au@medisca.com | www.medisca.com.au | 1300 786 392





FORMULATION SUPPORT

Compounding can offer relief and stability during potential drug shortages and MEDISCA Network’s formulation support can assist during these times. Access to MEDISCA Network formulations including, antiseptic solutions, emergency medications, antipyretics, disease-modifying antirheumatic drugs, nutraceuticals, among more, are freely accessible and continually being updated:

MEDISCA Network’s Potential Shortage Support

Contact Information: information@medisca.net | www.medisca.net | 1-866-333-7811




X

We have placed cookies on your device to help make this website better.

We also use cookies to collect information for making reports and to help us improve the site. The cookies collect information in an anonymous form.



Copyright® 1989-2020 Medisca Inc.
All rights reserved

MEDISCA is ISO 9001:2008 certified